Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 4:21 PM ET

Date/Time Source News Release
12/19/2024 08:30 AM EST GlobeNewswire ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21
12/11/2024 06:30 AM EST GlobeNewswire ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
11/14/2024 09:00 AM EST GlobeNewswire ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
10/22/2024 08:45 AM EDT GlobeNewswire ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
08/15/2024 07:30 AM EDT GlobeNewswire ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
04/17/2024 09:00 AM EDT GlobeNewswire ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
04/10/2024 08:30 AM EDT GlobeNewswire ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
03/26/2024 08:30 AM EDT GlobeNewswire ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
03/21/2024 08:30 AM EDT GlobeNewswire AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
02/27/2024 08:30 AM EST GlobeNewswire ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Page

Additional News

As of June 3, 2025 • 4:21 PM ET

Date/Time Source News Release
06/03/2025 06:06 AM EDT NewMediaWire ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value
05/22/2025 04:12 PM EDT SeekingAlpha ABVC BioPharma announces $100M mixed shelf offering
05/16/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, May 16th, 2025
05/16/2025 05:30 AM EDT US Earnings Reports Expected earnings - ABVC BioPharma Inc.
05/14/2025 09:06 AM EDT NewMediaWire ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
05/12/2025 02:20 PM EDT PRISM News PRISM Mid-Day Movers: Crypto Strategy and Fitness Investor Day Boost Emerging Indexes
05/09/2025 09:04 AM EDT NewMediaWire ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
05/01/2025 08:37 AM EDT NewMediaWire ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
04/16/2025 09:04 AM EDT NewMediaWire UPDATE: ABVC BioPharma Announces 2024 Financial Results
04/15/2025 04:37 PM EDT NewMediaWire ABVC BioPharma Announces 2024 Financial Results
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.